These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel α-ketoamide based diazeniumdiolates as hydrogen peroxide responsive nitric oxide donors with anti-lung cancer activity. Fu J; Han J; Meng T; Hu J; Yin J Chem Commun (Camb); 2019 Oct; 55(86):12904-12907. PubMed ID: 31584577 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates. Bharadwaj G; Benini PG; Basudhar D; Ramos-Colon CN; Johnson GM; Larriva MM; Keefer LK; Andrei D; Miranda KM Nitric Oxide; 2014 Nov; 42():70-8. PubMed ID: 25192820 [TBL] [Abstract][Full Text] [Related]
8. Targeted diazeniumdiolates: localized nitric oxide release from glioma-specific peptides and proteins. Safdar S; Taite LJ Int J Pharm; 2012 Jan; 422(1-2):264-70. PubMed ID: 22101282 [TBL] [Abstract][Full Text] [Related]
9. O Li Q; Zou P; Sun J; Chen L Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794 [TBL] [Abstract][Full Text] [Related]
10. Competitive formation of N-diazeniumdiolates and N-nitrosamines via anaerobic reactions of polyamines with nitric oxide. Coneski PN; Schoenfisch MH Org Lett; 2009 Dec; 11(23):5462-5. PubMed ID: 19899748 [TBL] [Abstract][Full Text] [Related]
11. Aryl bis(diazeniumdiolates): potent inducers of S-glutathionylation of cellular proteins and their in vitro antiproliferative activities. Andrei D; Maciag AE; Chakrapani H; Citro ML; Keefer LK; Saavedra JE J Med Chem; 2008 Dec; 51(24):7944-52. PubMed ID: 19053760 [TBL] [Abstract][Full Text] [Related]
12. The nitric oxide prodrug JS-K and its structural analogues as cancer therapeutic agents. Maciag AE; Saavedra JE; Chakrapani H Anticancer Agents Med Chem; 2009 Sep; 9(7):798-803. PubMed ID: 19538173 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide (NO)- and nitroxyl (HNO)-generating diazeniumdiolates (NONOates): emerging commercial opportunities. Keefer LK Curr Top Med Chem; 2005; 5(7):625-36. PubMed ID: 16101424 [TBL] [Abstract][Full Text] [Related]
14. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies. Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140 [TBL] [Abstract][Full Text] [Related]
15. NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds. Konter J; Möllmann U; Lehmann J Bioorg Med Chem; 2008 Sep; 16(17):8294-300. PubMed ID: 18710813 [TBL] [Abstract][Full Text] [Related]
17. Photocontrollable nitric oxide (NO) and nitroxyl (HNO) donors and their release mechanisms. Nakagawa H Nitric Oxide; 2011 Aug; 25(2):195-200. PubMed ID: 21193058 [TBL] [Abstract][Full Text] [Related]
18. Novel anticancer hybrids from diazen-1-ium-1,2-diolate nitric oxide donor and ROS inducer plumbagin: Design, synthesis and biological evaluations. Bao N; Ou J; Li N; Zou P; Sun J; Chen L Eur J Med Chem; 2018 Jun; 154():1-8. PubMed ID: 29772386 [TBL] [Abstract][Full Text] [Related]
19. Diazeniumdiolated carbamates: a novel class of nitric oxide donors. Nandurdikar RS; Maciag AE; Cao Z; Keefer LK; Saavedra JE Bioorg Med Chem; 2012 Mar; 20(6):2025-9. PubMed ID: 22356735 [TBL] [Abstract][Full Text] [Related]
20. HNO and NO release from a primary amine-based diazeniumdiolate as a function of pH. Salmon DJ; Torres de Holding CL; Thomas L; Peterson KV; Goodman GP; Saavedra JE; Srinivasan A; Davies KM; Keefer LK; Miranda KM Inorg Chem; 2011 Apr; 50(8):3262-70. PubMed ID: 21405089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]